Sign up to save your podcasts
Or
Share Residual Risk in CAD: What Remains, Why It Matters, What to Do 🫀⚠️💡
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Residual Risk in CAD: What Remains, Why It Matters, What to Do 🫀⚠️💡
đź«€ Residual Risk in Coronary Artery Disease
Even after "optimal" therapy, many patients remain at risk. Why? Because atherosclerosis is more than LDL—it's thrombosis 🩸, inflammation 🔥, and metabolism ⚖️ working in concert.
This FAQ-based slide deck distills contemporary insights on residual thrombotic, lipid, metabolic, and inflammatory risk, and highlights emerging therapies—from dual-pathway inhibition 💊 to GLP-1 receptor agonists 🧬 and colchicine—that help close the gap between treatment and outcomes.
đź“Š Key message: precision, not complacency.
#Cardiology #SecondaryPrevention #ResidualRisk #CAD #PrecisionMedicine
View all episodes
By Dr RR Baliga, MD, MBA
5
66 ratings
đź«€ Residual Risk in Coronary Artery Disease
Even after "optimal" therapy, many patients remain at risk. Why? Because atherosclerosis is more than LDL—it's thrombosis 🩸, inflammation 🔥, and metabolism ⚖️ working in concert.
This FAQ-based slide deck distills contemporary insights on residual thrombotic, lipid, metabolic, and inflammatory risk, and highlights emerging therapies—from dual-pathway inhibition 💊 to GLP-1 receptor agonists 🧬 and colchicine—that help close the gap between treatment and outcomes.
đź“Š Key message: precision, not complacency.
#Cardiology #SecondaryPrevention #ResidualRisk #CAD #PrecisionMedicine
More shows like Dr RR Baliga's "Got Knowledge Doc" Podkast
View all
This Week in Cardiology
906 Listeners
The Curbsiders Internal Medicine Podcast
3,383 Listeners
The Mel Robbins Podcast
20,555 Listeners